Oral Answers to Questions

Julian Sturdy Excerpts
Tuesday 10th March 2020

(4 years ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Helen Whately Portrait Helen Whately
- Hansard - - - Excerpts

My hon. Friend makes a really important point about support for carers and young carers. I cannot answer on the details of his question right now, but I will take it away, talk to the Under-Secretary of State, my hon. Friend the Member for Bury St Edmunds (Jo Churchill), who is responsible for primary care, and the Under-Secretary of State, my hon. Friend the Member for Mid Bedfordshire (Ms Dorries), who is responsible for mental health, and come up with a better answer for him.

Julian Sturdy Portrait Julian Sturdy (York Outer) (Con)
- Hansard - -

10. What steps his Department is taking to increase the range of medicines available to patients on the NHS.

Matt Hancock Portrait The Secretary of State for Health and Social Care (Matt Hancock)
- Hansard - - - Excerpts

The systems that we have in place are already securing access to effective new medicines for many thousands of NHS patients—for instance, cystic fibrosis patients through the drug Orkambi. Our commitment to getting new drugs into the NHS through an innovative medicines fund will further expand the access to medicines for NHS patients.

Julian Sturdy Portrait Julian Sturdy
- Hansard - -

My right hon. Friend is aware that two children in my constituency have families who are self-funding the cannabis drug Bedrolite, which is their only means of controlling their severe epilepsy. He has very kindly agreed to meet me to discuss their case, but what action is being taken to make Bedrolite available on the NHS for families such as the two in my constituency for whom this really is the last resort?

Matt Hancock Portrait Matt Hancock
- Hansard - - - Excerpts

My hon. Friend is right to raise this issue, and I look forward to meeting him later this month to discuss it. These are desperately difficult cases. We have to trust doctors to make the right clinical decisions for each individual patient. Two licensed cannabis-based medicines have recently been made available for prescribing on the NHS. We keep working hard with the health system, and with industry and researchers, to improve the evidence base. Also, the costs need to be brought down by industry. Last week, the Under-Secretary of State, my hon. Friend the Member for Bury St Edmunds (Jo Churchill), held a roundtable with leading industry figures. I look forward to continued work to make sure that we can get these drugs to the people who need them.